Twist Bioscience (TWST) Short term Debt (2018 - 2021)

Twist Bioscience (TWST) has 4 years of Short term Debt data on file, last reported at $9.1 million in Q4 2021.

• Short term Debt for Q4 2021 came in at $9.1 million, up 172.49% year-over-year; the trailing twelve-month figure through Dec 2021 was $9.1 million (up 172.49% YoY), and the FY2021 annual result was $1.6 million, down 53.44% from the prior year.
• Short term Debt advanced to $9.1 million in Q4 2021 per TWST's latest filing, from $1.6 million in the prior quarter.
• Over five years, Short term Debt peaked at $9.1 million in Q4 2021 and troughed at $1.6 million in Q3 2021.
• A 4-year average of $3.5 million and a median of $3.3 million in 2018 frame the typical range for Short term Debt.
• On a YoY basis, Short term Debt climbed as much as 172.49% in 2021 and fell as far as 53.44% in 2021.
• A 4-year view of Short term Debt shows it stood at $3.3 million in 2018, then changed by 0.0% to $3.3 million in 2019, then changed by 0.0% to $3.3 million in 2020, then jumped by 172.49% to $9.1 million in 2021.
• Business Quant data shows TWST's Short term Debt at $9.1 million in Q4 2021, $1.6 million in Q3 2021, and $2.4 million in Q2 2021.